Multi-ingredient supplement may reduce knee pain in active individuals: Study

Hand close-up of young male athlete holding his injured knee during outdoor exercise.
Multi-ingredient blend may reduce knee pain (Getty Images)

A multi-ingredient joint health formula improved exercise tolerance in individuals with knee pain, according to a recent pilot study.

The supplement, containing collagen, curcumin, and hydrolyzed bone powder, enabled endurance-trained adults to perform more load-bearing repetitions after 12 weeks of use, according to research published in Nutrients.

“The benefits were most pronounced in load-sensitive functional outcomes and under acute endurance stress; the pattern of results is hypothesis-generating for a future confirmatory trial,” wrote researchers at Nankai University in China.

Knee pain during or after exercise is one of the most common complaints among recreational and competitive endurance athletes. Unlike degenerative joint conditions such as osteoarthritis, knee pain in otherwise healthy people is often intermittent and load-dependent. Because athletes may reduce their load and compensate by moving differently, there is a risk of joint degeneration or overuse injuries from the compensatory use of muscles and joints.

Nutritional intervention is a promising strategy for supporting joint health in active people. Rather than single formulations such as glucosamine, multi-ingredient supplements can target multiple biological mechanisms, including cartilage health, oxidative stress, inflammation, and tissue repair.

The supplement used in the study may have beneficial complementary effects. Type 2 collagen supports immunity and the cartilage matrix; curcumin has anti-inflammatory properties; and hydrolyzed bone powder is a natural source of the core structural component chondroitin sulfate.

Study details

Explore related questions

The study involved 60 endurance-trained adults with activity-related knee discomfort who were randomly assigned to three groups: Group A received a multi-ingredient formula (undenatured type II collagen, curcumin phytosome, and enzymatically hydrolyzed bone powder); Group B received glucosamine hydrochloride plus chondroitin sulfate; and Group C received a placebo.

The participants took their assigned supplement daily for 12 weeks and maintained their usual diet and exercise regimens. They were assessed at the start of the study and at week 6, week 12, and 24 h after a post-intervention half-marathon challenge. The primary outcome measured was the change in single-leg step-down (SLSD) repetitions to a pain level of 5 to evaluate their load-bearing capacity.

The results showed that at week 12, group A exceeded placebo for SLSD repetitions to pain levels 2 and 5 and for the visual analog scale (VAS) pain. Group B differed from placebo for SLSD pain level 2 and VAS but not for the SLSD pain level 5.

The researchers noted that the pain level results carry potential functional implications: “Pain level 2 reflects an early discomfort threshold, while pain level 5 represents high-threshold pain tolerance under repetitive loading—a metric conceptually more relevant to training persistence in endurance athletes,” they wrote.

Following the half-marathon, group A was the only group that didn’t show declines in range of motion (ROM), although between-group contrasts were not significant, and the researchers advised interpreting these results cautiously.

They acknowledged the small sample size and recommended future trials to confirm their hypothesis-generating findings.

“These findings support the need to conduct a larger confirmatory trial evaluating this multi-ingredient strategy for managing activity-related knee discomfort in active populations,” they wrote.


Source: Nutrients 2026, 18(22), 3785; https://doi.org/10.3390/nu18223785 (registering DOI), “A 12-Week Multi-Ingredient Joint Health Supplement Alleviates Activity-Related Knee Discomfort and Improves Pain-Limited Load Tolerance in Endurance-Trained Adults: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.” Authors: W. Gu et al.